Cipher Pharmaceuticals reaches cumulative sales milestone for Lipofen Cipher Pharmaceuticals Inc. today announced that it reached a cumulative sales milestone for Lipofen, the Company’s fenofibrate product. Achieving this target triggers a US$1.0 million milestone payment from Kowa Pharmaceuticals America Inc., Cipher’s U.S. Distribution and marketing partner, which is reflected in Cipher’s revenue for the second quarter of fiscal 2010. Kowa continues to do an excellent job with the advertising of Lipofen, having grown prescriptions in recent quarters solidly, said Larry Andrews, President and CEO of Cipher. This milestone additional strengthens our financial position to support our growth. .‘It’s an excellent public health triumph,’ he informed CBS News. ‘We have a lot more work to proceed but we’re not beginning from scratch.’ The American Cancer Society hopes to improve that true amount to 80 % of adults over 50 getting screened. A colonoscopy is preferred every a decade for adults over 50 years. The new record was published March 17 in the society’s medical journal, CA: A Cancers Journal for Clinicians. CBS Evening News Colonoscopies save lives, but they’re not ideal A new study published in The New England Journal of Medicine discovered colonoscopies can prevent 40 % of most cases of cancer of the colon by getting p.